Target Name: RTL8B
NCBI ID: G441518
Review Report on RTL8B Target / Biomarker Content of Review Report on RTL8B Target / Biomarker
RTL8B
Other Name(s): family with sequence similarity 127 member C | CXX1c | SIRH4 | RTL8B_HUMAN | retrotransposon Gag like 8B | MAR8B | mammalian retrotransposon-derived 2 | Retrotransposon Gag like 8B | protein FAM127C | FAM127C | mammalian retrotransposon derived protein 8B | Sushi-Ichi retrotransposon homolog 1 | Retrotransposon Gag-like protein 8B | Mammalian retrotransposon derived protein 8B

Understanding RTL8B: A Potential Drug Target Or Biomarker

RTL8B, a member of the RTL8 gene family with sequence similarity of 127, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. The RTL8B gene is located on chromosome 19 at position 618.2 and has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion.

One of the unique features of RTL8B is its ability to form double-stranded RNA structures, which are highly stable and can be easily isolated and purified. This property has led to the possibility of using RTL8B as a therapeutic agent, as double-stranded RNA structures have been shown to have various biological functions, including regulating gene expression and influencing cellular processes.

In addition to its potential as a drug target, RTL8B also has the potential to serve as a biomarker for various diseases. For example, the expression of RTL8B has been shown to be downregulated in various cancer types, which suggests that it may be a promising biomarker for cancer diagnosis and treatment. Additionally, the highly stable double-stranded RNA structures of RTL8B make it a potential candidate for use as a diagnostic agent for genetic disorders.

The potential drug target for RTL8B is its role in cell adhesion and migration. RTL8B has been shown to play a role in the regulation of cell-cell adhesion by influencing the formation of tight junctions and cadherins, which are important for maintaining tissue structure and function . Additionally, RTL8B has been shown to regulate the migration of cancer cells, which suggests that it may be a potential target for cancer therapies that aim to inhibit cell migration.

Another potential drug target for RTL8B is its role in the regulation of cell proliferation. RTL8B has been shown to play a role in the regulation of cell proliferation by influencing the expression of genes involved in cell cycle progression and apoptosis. Additionally, the highly stable double -stranded RNA structures of RTL8B have been shown to play a role in the regulation of cellular processes that are critical for cell proliferation, such as the G1/S transition and the G0/G1 transition.

In conclusion, RTL8B is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique ability to form double-stranded RNA structures and its involvement in various cellular processes make it a promising candidate for both drug development and biomarker research. Further studies are needed to fully understand the potential of RTL8B as a drug or biomarker, and to determine its exact mechanism of action.

Protein Name: Retrotransposon Gag Like 8B

The "RTL8B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RTL8B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RTL8C | RTL9 | RTN1 | RTN2 | RTN3 | RTN4 | RTN4IP1 | RTN4R | RTN4RL1 | RTN4RL2 | RTP1 | RTP2 | RTP3 | RTP4 | RTP5 | RTRAF | RTTN | RUBCN | RUBCNL | RUFY1 | RUFY2 | RUFY3 | RUFY4 | RUNDC1 | RUNDC3A | RUNDC3A-AS1 | RUNDC3B | RUNX1 | RUNX1-IT1 | RUNX1T1 | RUNX2 | RUNX2-AS1 | RUNX3 | RUNX3-AS1 | RUSC1 | RUSC1-AS1 | RUSC2 | RUSF1 | RUVBL1 | RUVBL1-AS1 | RUVBL2 | RWDD1 | RWDD2A | RWDD2B | RWDD3 | RWDD3-DT | RWDD4 | RXFP1 | RXFP2 | RXFP3 | RXFP4 | RXRA | RXRB | RXRG | RXYLT1 | Ryanodine receptor | RYBP | RYK | RYR1 | RYR2 | RYR3 | RZZ complex | S100 Calcium Binding Protein | S100A1 | S100A10 | S100A11 | S100A11P1 | S100A12 | S100A13 | S100A14 | S100A16 | S100A2 | S100A3 | S100A4 | S100A5 | S100A6 | S100A7 | S100A7A | S100A7L2 | S100A7P1 | S100A8 | S100A9 | S100B | S100G | S100P | S100PBP | S100Z | S1PR1 | S1PR1-DT | S1PR2 | S1PR3 | S1PR4 | S1PR5 | SAA1 | SAA2 | SAA2-SAA4 | SAA3P | SAA4 | SAAL1 | SAC3D1